Innovation Recognition for Censo Biotechnologies at SLAS2018
Censo Biotechnologies is one of eight companies selected to exhibit on 'Innovation AveNEW' at SLAS2018 in San Diego from the 3rd to 7th February.
SLAS is an annual conference and exhibition for the life sciences community. Scores of new technology make their debut at this prestigious event, introducing brand new life sciences innovation and providing an opportunity to interact with product developers, and to learn how these breakthrough technologies can benefit organisations.
Innovation AveNEW participants were selected by a committee of SLAS volunteers that judges applicants based on a set of criteria that includes the impact of the technology, commercial viability, and potential impact on the field of laboratory automation and technology.
In addition our poster abstract has been selected for presentation and Poster number 1331-B, titled 'iPSC Derived Microglia-like Cells', will be presented on February 5th between 5pm and 6pm by our Chief Business Officer, Simon MacKenzie.
Simon will also be presenting 'Assessing patient population therapeutic response variability using human iPSC derived microglia' at Late Night with LRIG, Session 2 on February 5th at 6.40pm.